Market research company EvaluatePharma recently released its World Preview 2019, Outlook to 2024 report. This report identified the current candidates that the company projects will be the biggest winners in 2024. Here are the five most valuable pipeline drugs in development -- and the stocks that are poised to profit from these drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,